Orna is developing a new treatment that uses circular RNA and specialized lipid particles to prompt a patient's own body to produce the cell therapies needed to fight disease. The technology has the potential to "unlock an entirely new class of genetic medicines and cell therapies for patients who today have limited or no treatment options," said Francisco Ramírez-Valle, senior vice president and head of Immunology Research and Early Clinical Development at Eli Lilly, in a statement.
A former West Coast biotech CEO has just been sentenced to more than two years in federal prison for misleading investors and stealing millions of dollars, the United States Attorney's Office for the District of Maryland announced on Monday. According to court documents and news releases, 62-year-old Oregon resident Nader Pourhassan, who was once the CEO of CytoDyn, defrauded investors from 2018 to 2021 regarding the commercialization of CytoDyn's product, a monoclonal antibody called Leronlimab.
The defense ministry has announced that it's funding research and development at SWARM Biotactics to create technology that can "steer cockroaches and send them on reconnaissance missions," CBS News reported. CEO Stefan Wilhelm said the cockroaches are "super resilient" and can crawl through "tiny spaces," climb up walls, go into pipes, and navigate through rubble. How does this work? Neuroscientists at the company put electrodes on the critters' antennae to "stimulate the insects' natural ability to navigate."
Imagine you're the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I'm not talking about the prospect of a coup or a revolution, or even a democratic election: I'm talking about the thing even more certain in life than taxes. I'm talking about death.
China's state broadcaster CCTV, which livestreamed the event to global media outlets, including The Associated Press and Reuters news agencies, reported that its coverage drew 1.9 billion views online and more than 400 million on television. As Putin and Xi approached Tiananmen Square's rostrum, Putin's interpreter was heard in Chinese saying: Biotechnology is continuously developing. Human organs can be continuously transplanted. The longer you live, the younger you become, and [you can] even achieve immortality. Xi, who was not on camera, responded: Some predict that in this century humans may live to 150 years old.
Flash forward to today, and the landscape couldn't look more different. For starters, thanks to accessible education and unfiltered reviews, social media has democratized the industry. Niche names now rival (and often replace) the big players, formulas have gotten cleaner and more sustainable, and new formats - lotions, solids, and more - share shelf space with traditional spritzes and sprays.
There was a time when nothing in cinema was more frightening than a xenomorph. HR Giger's nightmarish biomechanical hellspawn, dripping with fluids and Freudian discharge, was the gruesome, undisputed apex predator of movie monsters. It burst from your chest; it dissolved your face with acid; it splintered your ribcage like a pinata filled with blood and screams. It was unstoppable, unknowable, the kind of thing you'd expect to find at the bottom of your dishwasher after leaving it closed for 36 centuries.
Cornell has secured a 10-year, $10 million grant renewal to continue work aimed at spurring economic impact and job growth through applied research, development and commercialization of breakthrough technologies.
Scientists fear that the restrictions on Covid mRNA vaccines may impede progress in mRNA cancer research, potentially stalling advancements in treating aggressive cancers such as pancreatic cancer.
"We're able to transform a prolific environmental and societal waste into such a globally important medication in a way that's completely impossible, using chemistry alone or using biology alone," says study coauthor Stephen Wallace, a chemical biotechnologist at the University of Edinburgh in Scotland.
While big names get the spotlight, smaller healthcare stocks often hold the most explosive upside, with potential for significant gains in the coming years.
If there are fewer medical diagnostics there will be fewer medical devices and treatments. Real innovation is a function of risk and reward in a mathematical sense.
